These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 17520892)
1. [Present-day problems of clinical pharmacogenetics]. Kukes VG; Sychev DA; Gasanov NA Klin Med (Mosk); 2007; 85(2):58-63. PubMed ID: 17520892 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic testing in psychiatry: a review of features and clinical realities. de Leon J; Arranz MJ; RuaƱo G Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics: from bench to byte. Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in drug discovery and development: a translational perspective. Roses AD Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic studies of epilepsy drugs: are we there yet? Spurr NK Trends Genet; 2006 May; 22(5):250-2. PubMed ID: 16564110 [TBL] [Abstract][Full Text] [Related]
7. From "magic bullet" to "specially engineered shotgun loads": the new genetics and the need for individualized pharmacotherapy. Erickson RP Bioessays; 1998 Aug; 20(8):683-5. PubMed ID: 9780843 [TBL] [Abstract][Full Text] [Related]
8. The Affymetrix DMET platform and pharmacogenetics in drug development. Deeken J Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics: using DNA to optimize drug therapy. Lanfear DE; McLeod HL Am Fam Physician; 2007 Oct; 76(8):1179-82. PubMed ID: 17990842 [TBL] [Abstract][Full Text] [Related]
10. Evolution of pharmacogenomics. Somogy A Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in solid organ transplantation: current status and future directions. de Jonge H; Kuypers DR Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854 [TBL] [Abstract][Full Text] [Related]
13. Designing and implementing special-purpose databases: lessons from the pharmacogenetic network. Nadkarni P; Sun K; Wiepert M Pharmacogenomics; 2002 Sep; 3(5):687-96. PubMed ID: 12223053 [TBL] [Abstract][Full Text] [Related]
14. Fundamentals of pharmacology and applications in pharmacogenetics. Al-Ghoul M; Valdes R Clin Lab Med; 2008 Dec; 28(4):485-97. PubMed ID: 19059057 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization. Crea F; Giovannetti E; Zinzani PL; Danesi R Crit Rev Oncol Hematol; 2009 Oct; 72(1):21-44. PubMed ID: 19111474 [TBL] [Abstract][Full Text] [Related]
17. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group. Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D; Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908 [TBL] [Abstract][Full Text] [Related]
18. Translation of pharmacogenetic knowledge into cancer therapeutics. Yong WP; Innocenti F Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411 [TBL] [Abstract][Full Text] [Related]